Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ACTRN12626000266369) titled 'Ketamine for Post Traumatic Stress Disorder (PTSD): Feasibility and patient experience' on March 3.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Type of endpoint: Efficacy
Primary Sponsor: University of Otago
Condition:
PTSD
PTSD
Mental Health - Other mental health disorders
Intervention:
In the present study we propose investigating the feasibility of the use of a particular oral Ketamine (Ketalar(R) active ingredient: Ketamine hydrochloride). Dosing regimen with start with 5 consecutive days of stepwise increases of oral Ketamine from .5 to 2mg/kg (for ...